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Whi3 binds the mRNA of the
G1 cyclin CLN3 to modulate
cell fate in budding yeast
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Martí Aldea1,4
1Departament de Ciències Mèdiques Bàsiques, Universitat de
Lleida, 25198 Lleida, Catalunya, Spain; 2Cold Spring Harbor
Laboratory, Cold Spring Harbor, New York 11724, USA
Eukaryotic cells commit in G1 to a new mitotic cycle or
to diverse differentiation processes. Here we show that
Whi3 is a negative regulator of Cln3, a G1 cyclin that
promotes transcription of many genes to trigger the G1/S
transition in budding yeast. Whi3 contains an RNA-rec-
ognition motif that specifically binds the CLN3 mRNA,
with no obvious effects on Cln3 levels, and localizes the
CLN3 mRNA into discrete cytoplasmic foci. This is the
first indication that G1 events may be regulated by lo-
cally restricting the synthesis of a cyclin. Moreover,
Whi3 is also required for restraining Cln3 function in
meiosis, filamentation, and mating, thus playing a key
role in cell fate determination in budding yeast.
Received March 26, 2001; revised version accepted
September 12, 2001.
Like most other eukaryotes, Saccharomyces cerevisiae
cells monitor internal and external signals to choose be-
tween developmental options in the G1 phase of the cell
cycle (Pringle and Hartwell 1981). Sexual pheromones
arrest haploid cells in G1 transiently, whereas nutrient
limitation causes a G1 arrest and a switch to either meio-
sis or pseudohyphal/invasive growth.
During mitotic proliferation, both external and inter-
nal signals are also integrated in G1 to coordinate cell
growth in mass with cell cycle entry. Once a critical cell
volume is attained in late G1, Cln3 bound to the cyclin-
dependent kinase Cdc28 somehow activates the tran-
scription factors SBF (Swi4/Swi6) and MBF (Mbp1/Swi6).
These in turn induce the expression of a large set of
genes in a process that leads to the G1/S transition (Tyers
et al. 1993; Dirick et al. 1995; Stuart and Wittenberg
1995; Spellman et al. 1998). Cln3 is already present in
early G1 cells, and Cln3 protein levels do not oscillate
much throughout the cell cycle. However, a posttrans-
lational mechanism that explains why SBF and MBF be-
come active only in late G1 (or at a critical cell size) is yet
to be found.
Here we show that Whi3, a recently identified protein
that regulates cell size in budding yeast (Nash et al.
2001), exerts a negative role on Cln3 function in the G1
phase. Whi3 shows a C-terminal domain very similar to
the RNA-recognition motif (RRM), and we show that it
binds the CLN3 mRNA specifically. However, Whi3
does not obviously affect the abundance or translation of
the CLN3 mRNA, or the overall Cln3 protein levels.
Rather, Whi3 localizes the CLN3 mRNA to distinct cy-
toplasmic foci that may locally restrict Cln3 synthesis to
modulate its activity. Importantly, we have found that
Whi3, also through its RNA-recognition motif, is neces-
sary for repressing Cln3 function when cells are chal-
lenged in G1 to decide among other developmental op-
tions such as meiosis or filamentation.
Results and Discussion
Whi3 negatively regulates Cln3 function in G1
The WHI3 gene has been isolated as a regulator of cell
size in budding yeast. Whi3-deficient cells show a 20%
reduction in cell size with no changes in growth rate
(Nash et al. 2001). To test a possible role of Whi3 in
regulating the G1 phase, we analyzed small (early G1)
cells obtained by elutriation from wild-type and whi3
mutant strains. Whi3-deficient cells budded and entered
S phase with a volume ∼25% smaller than wild-type
cells (Fig. 1A,B). These results suggest that Whi3 might
be specifically involved in setting cell size at the G1/S
transition, the point where Cln3 plays a rate-limiting
role (Cross 1988; Nash et al. 1988). Indeed, transcrip-
tional activation of G1/S genes such as CLN2, CLB5, and
SWI4 also took place at a smaller cell size in whi3 cells
(Fig. 1C). However, Cln3 protein and phosphorylation
levels (Fig. 1C) were not affected.
The effects of WHI3 on cell volume are dose-depen-
dent, and WHI3 overexpression causes a lethal arrest in
G1 (Fig. 2A,B; Nash et al. 2001). ModerateWHI3 overex-
pression also repressed transcription of CLN1, CLN2,
and CLB5 (Fig. 2C) by preventing their activation in late
G1 as deduced from elutriated cultures (Fig. 2E,F). Loss of
Whi3 therefore accelerates the expression of genes con-
trolled by SBF and MBF, and overproduction of Whi3
delays or represses expression of the same genes. The G1
arrest (but not the lethality) caused byWHI3 overexpres-
sion was suppressed by constitutive expression of CLN2
(data not shown), a condition able to compensate the
major cell cycle deficiencies of a cln3mutant (Stuart and
Wittenberg 1995). Furthermore, a C-terminal truncated
form of Swi4 that is largely independent of Swi6 or Cln3
(Baetz and Andrews 1999) was able to activate G1/S gene
expression during WHI3 overexpression (data not
shown). Again, however, lethality was not suppressed,
suggesting that overexpressed WHI3 may interfere with
additional targets. These observations are consistent
with the idea that Whi3 inhibits the activation of SBF
and MBF by Cln3. To cause a G1 arrest Whi3 should also
down-regulate other activators of Start, perhaps Cln1
and Cln2 (and see below), for we have found that Cdc24,
a protein that is retained in the nucleus by Far1 in hap-
loid cells and is exported to the cytoplasm depending on
Cdc28–Cln1,2 activity (Shimada et al. 2000), remains
nuclear in the G1 arrest caused by Whi3 overexpression
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(data not shown). In any event, neither the G1 arrest nor
the lethal effects caused by high doses of Whi3 can be
solely explained by its effects on Cln3 function through
SCB- and MCB-driven transcription, pointing to the ex-
istence of additional essential targets of Whi3.
To ask whether Whi3 regulates G1/S gene expression
via Cln3 we compared whi3, cln3, and double whi3 cln3
mutants. Deletion of WHI3 had no effect in a cln3 mu-
tant strain (see Fig. 5A, below); that is, cln3 is epistatic to
whi3 for cell size (and this is also true for other pheno-
types of whi3; see below), suggesting that Whi3 acts via
Cln3. In contrast, bck2, another mutation causing large
cell size at Start (Di Como et al. 1995; Wijnen and
Futcher 1999), was not epistatic to whi3 (data not
shown). These genetic results support the idea that Whi3
is a negative regulator of Cln3 function.
Whi3 binds the CLN3 mRNA specifically
The Whi3 protein contains a domain similar to the
RNA-recognition motif. Deletions and point mutations
destroying the putative RRM yield null alleles of WHI3
with respect to both cell size (Nash et al. 2001) and de-
velopmental defects (see below), which suggests that the
putative RRM is critical for the function of Whi3. To test
whether Whi3 is in fact an RNA-binding protein and
whether it binds the CLN3 mRNA specifically, we per-
formed pull-down assays with a Whi3–TAP fusion ex-
pressed from theWHI3 promoter in yeast cells (Fig. 3A).
The CLN3 mRNA was enriched more than 10-fold in
Whi3–TAP beads compared to untagged controls as mea-
sured by dot-blot analysis, but neither URA3 nor ACT1
mRNA ratios differed significantly from 1 (Fig. 3C). In
addition, despite the fact that the CLN3 mRNA is ex-
tremely unstable (Schneider et al. 1998), most CLN3
mRNA in the Whi3–TAP pull down was full length (Fig.
3B). Fusing the Whi3 RRM to the calmodulin-binding
peptide (Fig. 3D) allowed us to perform in vitro binding
assays and test a direct involvement of Whi3 in binding
Figure 1. Whi3-deficient cells enter the cell cycle at a smaller
cell size. Small G1 wild-type (wt) or mutant (whi3) cells were
grown in YPD at 30°C, and samples were taken at different time
points to plot (A) budding indexes versus cell volume mean
values, and (B) DNA content distributions. (C) Northern analy-
sis of G1/S genes, and Western analysis of Cln3 protein levels
from samples taken at the specified time points. The U2 RNA
and the HA cross-reacting band (*) served as loading controls.
Figure 2. WHI3 overexpression prevents Cln3 from inducing
G1/S gene expression and arrests cells in G1. Wild-type (wt) or
GAL1p–WHI3 (↑WHI3) cells were added to 2% galactose to in-
duce expression of WHI3, and samples were analyzed at 4 h or
otherwise-specified time points. (A) Phase-contrast micro-
graphs. (B) DNA content distributions. (C) Northern analysis of
G1/S genes and Western analysis of Whi3 and Cln3 protein lev-
els. (D) CLN3 mRNA distribution on polysomal profiles. Small
G1 cells were elutriated 60 min after galactose addition and
grown under inducing conditions to obtain (E) DNA content
distributions and perform (F) Northern analysis of G1/S genes.
Garí et al.
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the CLN3 mRNA. Similarly to the in vivo assays, the
Whi3 RRM was able to bind very efficiently and specifi-
cally to the CLN3mRNA in vitro (Fig. 3E). Although the
binding of CLN3 mRNA remained unaffected by the ad-
dition of cold yeast total RNA in a 10-fold excess, the
binding of URA3 and LEU2 mRNAs showed a fivefold
decrease (data not shown). Interestingly, the Whi3 RRM
was also able to bind the mRNAs of the two other G1
cyclins, CLN1 and CLN2, albeit with reduced efficiency,
whereas there was no binding to the mRNA of the S-
phase cyclin CLB5. These results reinforce the idea that
the G1 arrest caused by Whi3 overexpression may in-
volve the functional inhibition of all Cln cyclins. A pre-
liminary deletion analysis showed that the Whi3 RRM
may bind the CLN3 mRNA at more than one region,
although the 3 region of the CLN3 open reading frame
seems to contain the most important determinants for
binding to Whi3 (Fig. 3E; see below). These observations
support the idea that Whi3 acts as an RNA-binding pro-
tein, and that the CLN3 mRNA may be a direct target.
We therefore examined the effects of Whi3 on CLN3
mRNA and protein. Neither overexpression nor deletion
ofWHI3 had any apparent effect on CLN3mRNA levels,
or on Cln3 protein levels (Figs. 1C, 2C). The polysome
profile of CLN3 mRNA did not change during WHI3
overexpression (Fig. 2D), suggesting that translation of
Cln3 was not affected. We could see no effect of Whi3 on
levels of Cln3–Cdc28 histone H1 kinase activity (data
not shown) or Cln3 protein phosphorylation levels (Figs.
1C, 2C), which suggest that Whi3 does not directly in-
hibit Cln3–Cdc28 complexes.
Whi3 colocalizes with the CLN3 mRNA
into cytoplasmic foci
We next asked whether Whi3 could affect the localiza-
tion of CLN3 mRNA. Analysis by FISH showed that the
CLN3 mRNA forms discrete cytoplasmic foci in G2/M
cells (Fig. 4A), a property found in mRNAs that are lo-
calized to direct the encoded protein to specific cytoplas-
mic compartments (Bashirullah et al. 1998). The bright-
ness of these foci was greatly diminished in whi3 cells
(Fig. 4A), whereas unrelated mRNAs such as URA3 or
kanMX4 were unaffected (data not shown). In addition, a
CLN3 mRNA deletion construct (CLN31) that shows
reduced binding to the Whi3 RRM in vitro (see above)
also produced much dimmer particles (Fig. 4A). Levels of
CLN3 and CLN31 mRNAs were totally comparable
when detected by Northern analysis in otherwise wild-
type cells (Fig. 4B). Neither a CLN3 mRNA construct
that codes for an identically C-terminal truncated prod-
uct but retains the 3 mRNA sequences (CLN3-1), nor a
mutant that lacks the Start codon (cln3nt) affected par-
ticle appearance (Fig. 4A). Therefore, the localization of
CLN3 mRNA into these foci requires Whi3 and certain
CLN3 mRNA sequences, but does not require Cln3 pro-
tein or full translation of the CLN3mRNA. Immunoflu-
orescence showed that Whi3 was also present in cyto-
plasmic foci (Fig. 4C). A combination of FISH and im-
munofluorescence showed that the CLN3 mRNA foci
colocalized with a large fraction of the Whi3 foci (Fig.
4D). The fact that we could only clearly detect the CLN3
mRNA foci in G2/M cells could be attributed to the tran-
scriptional up-regulation of WHI3 during mitosis (Spell-
man et al. 1998; Gari et al., unpubl.). In addition, Whi3
overexpression increased the brightness of CLN3mRNA
foci in G1 cells (data not shown), suggesting that the
Whi3/CLN3 mRNA ratio may also be crucial for foci
formation and Cln3 function.
Localization of ASH1 mRNA particles into daughter
cells depends on efficient transport via the actin cyto-
skeleton (Jansen et al. 1996; Long et al. 1997; Takizawa
et al. 1997), whereas localization of other mRNAs in
higher eukaryotes depends on their movement via mi-
crotubules (Arn and Macdonald 1998; Bashirullah et al.
1998). Latrunculin or nocodazole treatment of cells,
which disrupts the actin or microtubule cytoskeletons,
respectively, did not affect CLN3mRNA foci appearance
or number (data not shown), suggesting that transport
may not be a key functional aspect of the CLN3 mRNA
foci. Rather, as Cln3 is an extremely short-lived protein
(Schneider et al. 1998), binding of Whi3 to the CLN3
mRNA could restrict both synthesis and presence of the
Cln3 protein to a narrow molecular environment. If this
environment were unfavorable for the activation of SBF
andMBF, then Cln3 function would be inhibited, despite
wild-type levels of Cln3 protein. Although Miller and
Cross (2000) did not detect endogenous Cln3 protein in
G1 cells or small-budded cells by immunofluoresence,
they used several genetic approaches to propose that
Figure 3. Whi3 binds the CLN3 mRNA. (A) For in vivo analy-
sis, WHI3–TAP and untagged yeast strains were used in pull-
down assays with IgG beads. Bound proteins detected with a
peroxidase anti-peroxidase antibody are shown. (B) Northern
detection of bound CLN3 mRNA. Total RNA is shown as con-
trol. (C) Dot-blot detection of bound CLN3, URA3, and ACT1
mRNAs. Plotted are the values obtained from Whi3–TAP cells
relative to untagged cells. (D) For in vitro analysis, the Whi3
RRM fused to the calmodulin-binding peptide (arrowhead) was
bound to calmodulin beads to perform RNA binding assays.
Shown are Coomassie-stained proteins in Whi3 RRM or control
cell extracts and beads. (E) Dot-blot detection of input and
bound RNAs to Whi3 RRM and control beads. Percentages of
bound to input values are plotted.
Whi3 binds a G1 cyclin mRNA to modulate cell fate
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Cln3 should exert a rate-limiting function in the
nucleus. By using a powerful signal-amplification
method for immunofluorescence we have been able to
detect endogenously expressed Cln3 in the cytoplasm of
all wild-type cells (Fig. 4E), with some cells also showing
a distinctive nuclear signal. In contrast, Whi3-deficient
cells showed a more general and brighter nuclear pattern,
including unbudded cells, suggesting that Whi3 regu-
lates a cytoplasmic event that, directly or indirectly, af-
fects the ability of Cln3 to accumulate in the nucleus.
Whi3 is required to repress Cln3 function during
meiosis and filamentous growth
Down-regulation of Cln3 function seems to be a key con-
dition for yeast cells to take other developmental options
in G1 such as meiosis, filamentous growth, and mating.
For example, Cln3 blocks the function of the meiotic
inducer Ime1, thus making mitosis and meiosis incom-
patible (Colomina et al. 1999). Whi3 may be important
for down-regulation of Cln3 in meiosis, because a homo-
zygous whi3 strain entered meiotic S phase and sporu-
lated very poorly, but a whi3 cln3 double mutant was as
proficient as the parental strain (Fig. 5B). Similarly, Cln3
has an inhibitory effect on filamentous growth (Loeb et
al. 1999), and whi3 has been independently identified in
a search for mutants unable to undergo pseudohyphal
differentiation (Mosch and Fink 1997). We therefore
asked whether the failure of whi3 cells to filament could
be alleviated by deletion of CLN3. Although deletion of
whi3 blocked pseudohyphal differentiation in diploid
strains and invasive growth in haploid strains, the cor-
responding double whi3 cln3 mutants showed similar
pseudohyphal and invasive growth ability as parental
strains (Fig. 5C,D). The behavior of awhi3RRMmutant
lacking the RNA-binding domain was indistinguishable
from a complete deletion of the WHI3 gene in all these
epistatic analyses (data not shown), which reinforces the
notion that the observed direct interaction of Whi3 with
the CLN3 mRNA plays an important role in regulating
G1 events. Finally,whi3 cells mate with low efficiencies,
and this defect shows strong genetic interactions with a
hyperactive allele of CLN3 (Nash et al. 2001). In sum-
mary, the observed G1 cell cycle and developmental de-
ficiencies of whi3 mutant cells can be all alleviated by
loss of CLN3, which confirms both the negative effect of
Whi3 on Cln3 function and the specificity of their func-
tional relationship.
Our results show that Whi3 inhibits Cln3 function,
and suggest that the direct binding of Whi3 to CLN3
mRNA in cytoplasmic foci may be important for this
inhibition. As Cln3 is an extremely short-lived protein,
localizing its translation to particular cytoplasmic re-
gions, or molecular environments, could modulate the
ability of Cln3 to reach its presumptive nuclear targets
and, hence, to induce G1/S gene expression at a proper
cell size during the budding mitotic cycle. As a possibil-
ity, the ratio of unstable activators of Start (e.g., CLN3
mRNA and/or Cln3) to stable inhibitors (e.g., Whi3) may
promptly reflect changes in growth rate versus mass or
volume, which could determine cell size at Start for a
particular set of external conditions. Whatever the pre-
cise molecular mechanism of inhibition, Whi3 is also
very important for repressing Cln3 function in other de-
velopmental options that yeast cells take in G1: meiosis,
filamentation, and mating (Fig. 5E). D-type cyclin hyper-
Figure 4. The CLN3 mRNA is localized to cytoplasmic foci
that depend on and colocalize with Whi3. (A) CLN3 mRNA
FISH analysis of wild-type (wt), cln3 as negative control, and
whi3 strains, as well as wild-type cells carrying a deletion in
the 3 region of the ORF (CLN3-1), the ORF-equivalent point
mutation (CLN3-1), or a nontranslatable CLN3mRNA (cln3nt).
(B) mRNA levels of the above CLN3 constructs detected by
Northern using the ACT1mRNA as loading control. (C) Immu-
nofluorescence of Whi3-HA cells (untagged cells as negative
control), showing also nuclei and merged images. (D) Combined
CLN3 mRNA FISH and Whi3-HA immunofluorescence, show-
ing also merged images. (E) Signal-amplification immunofluo-
rescence of Cln3-HA in wild-type (wt), whi3 mutant (whi3),
and untagged cells as negative control, showing also nuclei
stained with DAPI. Bars, 5 µm.
Garí et al.
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activity also perturbs cell size control in G1 (Ohtsubo
and Roberts 1993; Quelle et al. 1993) and inhibits differ-
entiation (Skapek et al. 1995; Zhang et al. 1999) in mam-
malian cells. Although an specific RNA-binding protein
has not yet been identified, localization of cyclin B1
mRNA by CPEB and maskin to the spindle and centro-
somes in Xenopus oocytes is important for spindle dy-
namics (Groisman et al. 2000). The further functional
and molecular characterization of the Whi3 device may
therefore help us understand how eukaryotic cells inte-
grate and centralize molecular information to regulate
their cycle and take different cell fate options.
Materials and methods
Strains, plasmids, and growth conditions
Yeast parental strains (1788, W303, and 1278), standard growing condi-
tions, and special media to induce sporulation, filamentation, or invasive
growth were as described (Roberts and Fink 1994; Gallego et al. 1997;
Colomina et al. 1999). Chromosomal gene disruptions, C-terminal fu-
sions to a triple HA epitope or the TAP tag, as well as gene fusions to the
GAL1 promoter were performed by gene transplacement methods as de-
scribed (Gallego et al. 1997). CLN3-1 carries a deletion from nucleotide
+1213 to the end of the CLN3ORF. CLN3-2 lacks the first 1212 nucleo-
tides of the CLN3ORF. CLN3-1 has a nonsense mutation at +1210 (Nash
et al. 1988), and cln3nt carries a point mutation that eliminates the Start
codon. Details of strain and plasmid constructions are available upon
request.
RNA-binding assays
Yeast cells expressing the Whi3–TAP protein were used in pull-down
assays (Rigaut et al. 1999). Washed IgG beads were eluted with 0.5% SDS,
10 mM EDTA, 10 mM HCl-Tris at pH 8 for 5 min at RT, and RNA was
isolated (Ausubel et al. 1999) to detect various mRNAs (CLN3, URA3,
and LEU2) by dot or Northern blot analysis (see below). As deduced from
Northern analysis, CLN3 mRNA stability was not particularly affected
during extract preparation when compared to URA3 and ACT1 mRNAs
used as internal controls. For in vitro binding assays, the Whi3RRM was
fused to the calmodulin-binding peptide (CBP) in pCAL-n and affinity-
purified on calmodulin beads (Stratagene), which were then used to test
binding of 32P-labeled RNAs synthesized from T7/T3-expression vectors
(Ausubel et al. 1999). Binding reactions contained 0.3 µg of 32P-labeled
RNA and 1 µg of either CBP–Whi3RRM or CBP bound to calmodulin
beads in cold CBB buffer (Stratagene). Binding was performed at 4°C for
1 h, beads were washed four times with cold CBB buffer, and bound
RNAs were eluted as described above and spotted on Nylon+ membranes
to quantify radioactivity with a Fuji BAS-1000 reader.
FISH and immunofluorescence
Cells were treated for FISH with a digoxigenin-labeled CLN3 riboprobe
essentially as described (Takizawa et al. 1997), using a detection method
based on development of a HNPP-fluorescent precipitate (Roche). As the
CLN3mRNA signal was significantly stronger during mitosis, cells were
treated with 10 µg/mL nocodazole for 90 min before fixation. Foci per cell
were counted in images all treated in such a way that negative control
cells (cln3) were already not distinguishable against the field back-
ground, and mean values were obtained by counting a minimum of 300
cells per sample. The localization of Whi3-HA was done by immunofluo-
resence (Colomina et al. 1999) with a rat anti-HA antibody (clone 3F10,
Roche), followed by incubation with Alexa488-labeled anti-rat antibody
(Molecular Probes). To combine FISH and immunofluoresence, rat anti-
HA and sheep alkaline-phosphatase anti-digoxigenin (Roche) antibodies
were added together after washing the probe, followed by incubation
with Alexa488-labeled anti-rat antibody, and HNPP precipitate develop-
ment as above. Cln3-HA was detected by a signal-amplification method
based on regular immunofluorescence procedures (Colomina et al. 1999).
Briefly, after incubation with rat anti-HA antibody, slides were sequen-
tially incubated with goat anti-rat, rabbit anti-goat, and goat anti-rabbit
antibodies labeled with Alexa488 (Molecular Probes).
Miscellaneous
Northern methods and probes used, as well as Western conditions to
detect specific tagged proteins, were done as described previously (Gal-
lego et al. 1997). TAP-tagged proteins were detected with a peroxidase-
labeled rabbit anti-peroxidase antibody soluble complex (Sigma) as de-
scribed (Rigaut et al. 1999). Cln3 immunoprecipitation and associated-
kinase assays were also as described (Tyers et al. 1993). The distribution
of the CLN3 mRNA in polysomes was analyzed in sucrose gradients
Figure 5. Cell size and developmental defects of Whi3-deficient cells depend on Cln3. Wild-type (wt), cln3, whi3, and double cln3
whi3mutant strains were used to analyze (A) cell volume distributions of haploid 1788 strains, (B) meiotic S-phase entry at 12 h and
sporulation efficiencies at 24 h of diploid 1788 strains, (C) pseudohyphal growth of diploid 1278 strains in SLAD plates, and (D)
invasive growth of haploid 1278 strains in YEPD plates. (E) Scheme to depict Whi3 and Cln3 functional interactions.
Whi3 binds a G1 cyclin mRNA to modulate cell fate
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(Cigan et al. 1991). Small G1 cells were obtained by elutriation (Tyers et
al. 1993). Cell volume distributions were obtained in a Z2 Coulter
Counter, and DNA content distributions and budding indexes were de-
termined as described (Gallego et al. 1997).
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